Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Five-Year Multicenter Cohort Study of Vaginal Microbiome and STIs Progression

10. november 2026 oppdatert av: Muxuan Chen, Shenzhen Maternity & Child Healthcare Hospital

A Five-Year Longitudinal Follow-Up Study on Vaginal Microbiome Characteristics and Their Association With Reproductive Tract STIs and Cervical Lesion Progression Based on a Multicenter Cohort

  1. To elucidate the long-term impact of vaginal microbiome and the dynamic trends of its characteristics across 5 years follow-up visits on the clinical outcomes of sexually transmitted infections (STIs).
  2. To determine the long-term effects of specific microbial infections (Up6, MH) and vaginal microbiome characteristics on the progression of STIs.

Studieoversikt

Status

Har ikke rekruttert ennå

Detaljert beskrivelse

This multicenter, observational study is a 5-year longitudinal follow-up extending the CALM2004 cohort. It aims to enroll 7,574 women aged 18-60 to investigate the long-term impact of vaginal microbiome characteristics and sexually transmitted infections (STIs) on cervical lesion progression. By collecting vaginal secretions, and blood samples, the study will evaluate the 5-year cumulative incidence of CIN2+ and determine how specific microbial infections (e.g., Up6, MH) influence clinical outcomes, providing high-level evidence for cervical cancer prevention strategies.

Studietype

Observasjonsmessig

Registrering (Antatt)

7574

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

    • Beijing Municipality
      • Beijing, Beijing Municipality, Kina
        • Peking University First Hospital
        • Ta kontakt med:
          • Bingbing Xiao, Doctor
    • Fujian
      • Fuzhou, Fujian, Kina
        • Fujian Maternity and Child Health Hospital
    • Gansu
      • Lanzhou, Gansu, Kina
        • The First Hospital of Lanzhou University
        • Ta kontakt med:
          • Haitao Yu, Doctor
      • Lanzhou, Gansu, Kina
        • Gansu Provincial Hospital
        • Ta kontakt med:
          • Lianhua Wei, Doctor
    • Guangdong
      • Chaozhou, Guangdong, Kina
        • Chaozhou Central Hospital
        • Ta kontakt med:
          • Fen lin, Doctor
      • Foshan, Guangdong, Kina
        • Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine
        • Ta kontakt med:
          • Chaoxin Jiang, Doctor
      • Guangzhou, Guangdong, Kina
        • The First Affiliated Hospital, Sun Yat-sen University
        • Ta kontakt med:
          • Bin Huang, Doctor
      • Guangzhou, Guangdong, Kina
        • Nanfang Hospital, Southern Medical University
        • Ta kontakt med:
          • Dehua Sun, Doctor
      • Guangzhou, Guangdong, Kina
        • The Fifth Affiliated Hospital of Southern Medical University
        • Ta kontakt med:
          • Xiaoyan Li, Doctor
      • Guangzhou, Guangdong, Kina
        • The First Affiliated Hospital of Guangzhou University of Chinese Medicine
        • Ta kontakt med:
          • Yingchun Zhou, Doctor
      • Guangzhou, Guangdong, Kina
        • The Fifth Affiliated Hospital of Guangzhou Medical University
        • Ta kontakt med:
          • Liang Peng, Doctor
      • Guangzhou, Guangdong, Kina
        • The Third Affiliated Hospital of Southern Medical University
        • Ta kontakt med:
          • Xuefeng Wang, Doctor
      • Guangzhou, Guangdong, Kina
        • The Third Affiliated Hospital of Guangzhou University of Chinese Medicine
        • Ta kontakt med:
          • Kewei Zhao, Doctor
      • Guangzhou, Guangdong, Kina
        • Zhujiang Hospital of Southern Medical University
      • Guangzhou, Guangdong, Kina
        • Guangzhou Baiyun District Taihe People's Hospital
      • Huizhou, Guangdong, Kina
        • Huizhou Municipal Central Hospital
        • Ta kontakt med:
          • Xianjin Wu, Doctor
      • Shaoguan, Guangdong, Kina
        • Yuebei People's Hospital
        • Ta kontakt med:
          • Pingsen Zhao, Doctor
      • Shenzhen, Guangdong, Kina, 518028
        • Shenzhen Maternity & Child Healthcare Hospital
        • Ta kontakt med:
          • Yuting Dai
          • Telefonnummer: 0755-82869849
      • Shenzhen, Guangdong, Kina
        • Luohu District People's Hospital
      • Shenzhen, Guangdong, Kina
        • Southern Medical University Shenzhen Hospital
        • Ta kontakt med:
          • Hongwei Zhou, Doctor
      • Shenzhen, Guangdong, Kina
        • The Seventh Affiliated Hospital, Sun Yat-sen University
        • Ta kontakt med:
          • Zhaofan Luo, Doctor
      • Zhongshan, Guangdong, Kina
        • Zhongshan Xiaolan People's Hospital
        • Ta kontakt med:
          • Wandang Wang, Doctor
      • Zhuhai, Guangdong, Kina
        • Zhuhai Maternal and Child Health Hospital
    • Guangxi
      • Nanning, Guangxi, Kina
        • The First Affiliated Hospital of Guangxi Medical University
        • Ta kontakt med:
          • Faquan Lin, Doctor
    • Guizhou
      • Guiyang, Guizhou, Kina
        • Affiliated Hospital of Guizhou Medical University
        • Ta kontakt med:
          • Fan Lu, Doctor
      • Zunyi, Guizhou, Kina
        • Zunyi First People's Hospital
        • Ta kontakt med:
          • Kaifeng Wu, Doctor
    • Hainan
      • Haikou, Hainan, Kina
        • Hainan General Hospital
        • Ta kontakt med:
          • Bo Wang, Doctor
    • Heilongjiang
      • Mudanjiang, Heilongjiang, Kina
        • Hongqi Hospital Affiliated to Mudanjiang Medical University
        • Ta kontakt med:
          • Chunxia Guo, Doctor
      • Qiqihar, Heilongjiang, Kina
        • Qiqihar First Hospital
    • Henan
      • Zhengzhou, Henan, Kina
        • Henan Provincial People's Hospital
        • Ta kontakt med:
          • Jing Zhao, Doctor
    • Inner Mongolia
      • Hohhot, Inner Mongolia, Kina
        • Inner Mongolia Autonomous Region Maternal and Child Health Hospital
        • Ta kontakt med:
          • Jing Sha, Doctor
    • Jiangsu
      • Lianyungang, Jiangsu, Kina
        • The Second People's Hospital of Lianyungang
        • Ta kontakt med:
          • Wei Liang, Doctor
    • Jilin
      • Jilin City, Jilin, Kina
        • Jilin City Central Hospital
        • Ta kontakt med:
          • Guijie Zhang, Doctor
    • Liaoning
      • Shenyang, Liaoning, Kina
        • The First Hospital of China Medical University
        • Ta kontakt med:
          • Ruizhe Wang, Doctor
    • Ningxia
      • Yinchuan, Ningxia, Kina
        • General Hospital of Ningxia Medical University
        • Ta kontakt med:
          • Feng Li, Doctor
    • Qinghai
      • Xining, Qinghai, Kina
        • Qinghai Red Cross Hospital
        • Ta kontakt med:
          • Dengyun Ma, Doctor
    • Shandong
      • Jinan, Shandong, Kina
        • Jinan Central Hospital
        • Ta kontakt med:
          • Shuyi Han, Doctor
      • Jinan, Shandong, Kina
        • Shandong Provincial Hospital
    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Kina
        • Shanghai East Hospital, Tongji University
        • Ta kontakt med:
          • Jingxin Cheng, Doctor
    • Shanxi
      • Changzhi, Shanxi, Kina
        • Changzhi People's Hospital
        • Ta kontakt med:
          • Guoxiang Zhang, Doctor
    • Sichuan
      • Dazhou, Sichuan, Kina
        • Dazhou Integrated Traditional Chinese and Western Medicine Hospital
        • Ta kontakt med:
          • Xuesu He, Doctor
      • Luzhou, Sichuan, Kina
        • Affiliated Hospital of Southwest Medical University
        • Ta kontakt med:
          • Jinbo Liu, Doctor
    • Tibet
      • Lhasa, Tibet, Kina
        • Tibet Autonomous Region People's Hospital

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 60 år (Voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Hunn

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

A total of 7,574 women aged 18-60 years who previously participated in the baseline of the CALM2004 multicenter cohort study will be recruited for this 5-year longitudinal follow-up. This is a multicenter study, and participants will be recruited through targeted invitations from the research team members. The study population consists of women with a broad spectrum of baseline vaginal microecological statuses and varying risks of STIs and cervical lesions.

Beskrivelse

Inclusion Criteria:

  1. Female aged 18 to 60 years.
  2. Participants who previously participated in the baseline of the CALM2004 study.
  3. Volunteers who are recruited through targeted invitations and consent to participate in this study.

Exclusion Criteria:

  1. Pregnant women.
  2. Received treatment for reproductive tract infections or sexually transmitted infections (STIs) within the past month.
  3. Used broad-spectrum antibiotics, local genital probiotics, or vaginal suppositories within the past month.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Observasjonsmodeller: COHORT
  • Tidsperspektiver: PROSPECTIVE

Kohorter og intervensjoner

Gruppe / Kohort
CALM2004 Follow-up Cohort

A total of 7,574 women aged 18-60 who previously participated in the CALM2004 baseline study will be enrolled for a 5-year longitudinal follow-up. Participants will undergo comprehensive assessments including questionnaires, vaginal secretion collection for metagenomic sequencing, cervical exfoliated cells for TCT and STI nucleic acid testing, and venous blood testing. No specific interventions will be administered.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Cumulative incidence of CIN2+ at 5 years
Tidsramme: 5 years

The incidence rate of histologically confirmed Cervical Intraepithelial Neoplasia grade 2 or 3 (CIN2/3) or invasive cervical cancer occurring for the first time during the follow-up period, among participants who had no cervical lesions or were <CIN2 at baseline

5 years

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
New incidence and progression rates of ASC-US+ cytological abnormalities
Tidsramme: 5 years

ASC-US+ new incidence: First occurrence of ASC-US or higher cytological abnormality during follow-up in participants with normal baseline cytology. ASC-US+ progression: First occurrence of LSIL/HSIL or higher cytological abnormality during follow-up in participants with baseline ASC-US. Cytology is evaluated according to the Bethesda System for Reporting Cervical Cytology.

5 years

Andre resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
HPV and STI incidence, clearance, and persistent/recurrent infection rates
Tidsramme: 5 years

HPV new infection: baseline negative, follow-up positive; HPV clearance: baseline positive, follow-up negative; HPV persistent infection: same genotype positive at both baseline and follow-up. STI new infection: baseline negative, follow-up positive; STI clearance: baseline positive, follow-up same genotype negative; STI recurrent infection: same genotype positive at both baseline and follow-up.

5 years

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Studiestol: Hongwei Zhou, Doctor, Shenzhen Hospital of Southern Medical University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

20. desember 2026

Primær fullføring (Antatt)

30. juni 2028

Studiet fullført (Antatt)

30. desember 2028

Datoer for studieregistrering

Først innsendt

10. november 2026

Først innsendt som oppfylte QC-kriteriene

10. november 2026

Først lagt ut (Faktiske)

17. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

17. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

10. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere